There has been much discussion and concern among physicians over the Obama administration’s call to overhaul the American healthcare system, but experts who spoke at this week’s Heart Rhythm 2009 conference in Boston said the best thing doctors can do is get involved.

May 14, 2009 - St. Jude Medical Inc. yesterday announced European CE mark approval of its Accent RF pacemaker and Anthem RF CRT-P (cardiac resynchronization therapy pacemaker).

May 14, 2009 - Partnering with Healthworks Inc., the Philips Learning Center is offering a series of live lecture webinars called “Electrophysiology: The Essentials.”

The series is presented by Jeffrey A. Stiffler, executive vice president, electrophysiology, and Marta Martinez, clinical specialist/education associate for Healthworks Inc.

May 14, 2009 – In final, one-year results of a multicenter randomized clinical study, catheter ablation demonstrated significantly better outcomes compared to anti-arrhythmic drug (AAD) therapy for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation (AF).

May 14, 2009 - Cardiola AG received CE mark recertification to market its m.pulse system for at-home use to treat chronic heart failure (CHF), the most frequent cause of hospitalization in persons 65 and older.

May 13, 2009 – Siemens Healthcare is demonstrating the clinical benefits of the world’s first volume intracardiac echocardiography (VICE) catheter, the ACUSON AcuNav V ultrasound catheter, this week at the 2009 Scientific Sessions of the Heart Rhythm Society in Boston, May 13-16.

May 13, 2009 - NewCardio Inc. this week is introducing the QTinno, an automated analysis of ECGs used to determine cardiac toxicity during drug development, and the Visual3Dx, which generates 3D information from the heart using standard 12-lead ECG data, during Heart Rhythm 2009 in Boston.

May 13, 2009 – Stereotaxis Inc. said this week the Heart Rhythm 2009 formal program contains 21 podium and poster presentations in which its Niobe system is either featured or discussed regarding the treatment of complex cardiac arrhythmias.

May 13, 2009 - Medtronic Inc. today announced the start of a nationwide trial to examine the relationship between the company’s OptiVol Fluid Status Monitoring technology and the ability to predict worsening heart failure, a leading cause of hospitalizations worldwide.

May 13, 2009 - St. Jude Medical Inc. today said it will display a number of new products and technologies at the annual Heart Rhythm Society meeting in Boston this week, including therapies and devices for the treatment of heart arrhythmias, including products enabled with wireless connectivity.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now